nach oben

Neurological Sciences

Erschienen in:

03.03.2020 | Review Article

Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders

Erschienen in: Neurological Sciences | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Eye tracking is a powerful method to investigate the relationship between behavior and neural mechanisms. In recent years, eye movement analysis has been used in patients with neurological disorders to assess cognitive function. In this review, we explore the latest eye tracking researches in neurological disorders that are commonly associated with cognitive deficits, specifically, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and epilepsy. We focus on the application of ocular measures in these disorders, with the goal of understanding how eye tracking technology can be used in the clinical setting.

Findings

Eye tracking tasks (especially saccadic tasks) are often used as an adjunct to traditional scales for cognitive assessment. Eye tracking data confirmed that executive dysfunction is common in PD and ALS, whereas AD and MS are characterized by attention deficits. Research in evaluating cognitive function in epilepsy using eye tracking is still in its early stages, but this approach has shown advantages as a sensitive quantitative method with high temporal and spatial resolution.

Summary

Eye tracking technology can facilitate the assessment of cognitive impairment with higher temporal resolution and finer granularity than traditional cognitive assessment. Oculomotor data collected during cognitive tasks can provide insight into biological processes. Eye tracking provides a nonverbal and less cognitively demanding method of measuring disease progression in cognitively impaired patients.

Gibaldi A, Vanegas M, Bex PJ et al (2017) Evaluation of the Tobii EyeX eye tracking controller and Matlab toolkit for research. Behav Res Methods 49:923–946

Pavisic IM, Firth NC, Parsons S et al (2017) Eyetracking metrics in young onset Alzheimer’s disease: a window into cognitive visual functions. Front Neurol 8:377PubMedCentral

Bekkering H, Neggers SF, Walker R et al (2001) The preparation and execution of saccadic eye and goal-directed hand movements in patients with Parkinson’s disease. Neuropsychologia 39:173–183

Jiang M, Liu S, Feng Q et al (2018) Usability study of the user-interface of intensive care ventilators based on user test and eye-tracking signals. Med Sci Monit 24:6617–6629PubMedCentral

Fielding J, Kilpatrick T, Millist L et al (2009) Multiple sclerosis: cognition and saccadic eye movements. J Neurol Sci 277:32–36

Keller J, Krimly A, Bauer L et al (2017) A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh cognitive and Behavioural ALS screen. Amyotroph Lateral Scler Frontotemporal Degener 18:443–450

Unger M, Black D, Fischer NM et al (2018) Design and evaluation of an eye tracking support system for the scrub nurse. Int J Med Robot. https://doi.org/10.1002/rcs.1954e1954

Wolf K, Galeano Weber E, van den Bosch JJF et al (2018) Neurocognitive development of the resolution of selective visuo-spatial attention: functional MRI evidence from object tracking. Front Psychol 9:1106PubMedCentral

Isbilir E, Cakir MP, Acarturk C et al (2019) Towards a multimodal model of cognitive workload through synchronous optical brain imaging and eye tracking measures. Front Hum Neurosci 13:375PubMedCentral

10.

Antoniades CA, Demeyere N, Kennard C et al (2015) Antisaccades and executive dysfunction in early drug-naive Parkinson’s disease: the discovery study. Mov Disord 30:843–847

11.

Asato MR, Nawarawong N, Hermann B et al (2011) Deficits in oculomotor performance in pediatric epilepsy. Epilepsia 52:377–385

12.

Bastin J, Lebranchu P, Jerbi K et al (2012) Direct recordings in human cortex reveal the dynamics of gamma-band [50–150 Hz] activity during pursuit eye movement control. Neuroimage 63:339–347

13.

Thickbroom GW, Black JL (1980) Eye motion kinetics in moving target pursuit—a system for detection of oculomotor abnormalities in neurological disorders. Int J Biomed Comput 11:427–439

14.

Jacobs L, Bozian D, Heffner RR Jr et al (1981) An eye movement disorder in amyotrophic lateral sclerosis. Neurology 31:1282–1287

15.

Krejtz K, Duchowski AT, Niedzielska A et al (2018) Eye tracking cognitive load using pupil diameter and microsaccades with fixed gaze. PLoS One 13:e0203629PubMedCentral

16.

Ortega Ade O, Ciamponi AL, Mendes FM et al (2009) Assessment scale of the oral motor performance of children and adolescents with neurological damages. J Oral Rehabil 36:653–659

17.

Irvine KA, Ferguson AR, Mitchell KD et al (2014) The Irvine, Beatties, and Bresnahan (IBB) forelimb recovery scale: an assessment of reliability and validity. Front Neurol 5:116PubMedCentral

18.

Holthoff VA, Ferris S, Ihl R et al (2011) Validation of the relevant outcome scale for Alzheimer’s disease: a novel multidomain assessment for daily medical practice. Alzheimers Res Ther 3:27PubMedCentral

19.

Kyroudi A, Petersson K, Ozsahin M et al (2017) Analysis of the treatment plan evaluation process in radiotherapy through eye tracking. Z Med Phys. https://doi.org/10.1016/j.zemedi.2017.11.002

20.

G. Burger, J. Guna, M. Pogacnik (2018) Suitability of inexpensive eye-tracking device for user experience evaluations. Sensors (Basel); 18

21.

Amador SC, Hood AJ, Schiess MC et al (2006) Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson’s disease patients. Neuropsychologia 44:1475–1482

22.

Crevits L, Vandierendonck A, Stuyven E et al (2004) Effect of intention and visual fixation disengagement on prosaccades in Parkinson’s disease patients. Neuropsychologia 42:624–632

23.

Farooqui AA, Bhutani N, Kulashekhar S et al (2011) Impaired conflict monitoring in Parkinson’s disease patients during an oculomotor redirect task. Exp Brain Res 208:1–10

24.

Ranchet M, Orlosky J, Morgan J et al (2017) Pupillary response to cognitive workload during saccadic tasks in Parkinson’s disease. Behav Brain Res 327:162–166

25.

Proudfoot M, Menke RA, Sharma R et al (2015) Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks. Amyotroph Lateral Scler Frontotemporal Degener 17:101–111PubMedCentral

26.

Girardi A, Macpherson SE, Abrahams S (2011) Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology 25:53–65

27.

Tan RH, Ke YD, Ittner LM et al (2017) ALS/FTLD: experimental models and reality. Acta Neuropathol 133:177–196

28.

Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131–146

29.

Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83:102–108

30.

Poletti B, Carelli L, Solca F et al (2017) An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol 264:1136–1145

31.

Witiuk K, Fernandez-Ruiz J, McKee R et al (2014) Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory task. J Neurosci 34:14260–14271PubMedCentral

32.

Keller J, Gorges M, Horn HT et al (2015) Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study. J Neurol 262:1918–1926

33.

Pasqualotto E, Matuz T, Federici S et al (2015) Usability and workload of access technology for people with severe motor impairment: a comparison of brain-computer interfacing and eye tracking. Neurorehabil Neural Repair 29:950–957

34.

Noiret N, Carvalho N, Laurent E et al (2018) Saccadic eye movements and attentional control in Alzheimer’s disease. Arch Clin Neuropsychol 33:1–13

35.

Beltran J, Garcia-Vazquez MS, Benois-Pineau J et al (2018) Computational techniques for eye movements analysis towards supporting early diagnosis of Alzheimer’s disease: a review. Comput Math Methods Med 2018:2676409PubMedCentral

36.

Ben Jemaa S, Attia Romdhane N, Bahri-Mrabet A et al (2017) An Arabic version of the cognitive subscale of the Alzheimer’s disease assessment scale (ADAS-cog): reliability, validity, and normative data. J Alzheimers Dis 60:11–21

37.

Dixon JS, Saddington DG, Shiles CJ et al (2017) Clinical evaluation of brief cognitive assessment measures for patients with severe dementia. Int Psychogeriatr 29:1169–1174

38.

Ihara R (2017) Current clinical assessment scales and cognitive tests in global clinical studies on Alzheimer’s disease. Brain Nerve 69:781–787

39.

Reul S, Lohmann H, Wiendl H et al (2017) Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation? Alzheimers Res Ther 9:61PubMedCentral

40.

Bott N, Madero EN, Glenn J et al (2018) Device-embedded cameras for eye tracking-based cognitive assessment: validation with paper-pencil and computerized cognitive composites. J Med Internet Res 20:e11143PubMedCentral

41.

Julayanont P, Brousseau M, Chertkow H et al (2014) Montreal cognitive assessment memory index score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer’s disease. J Am Geriatr Soc 62:679–684

42.

Daffner KR, Scinto LF, Weintraub S et al (1992) Diminished curiosity in patients with probable Alzheimer’s disease as measured by exploratory eye movements. Neurology 42:320–328

43.

Brandao L, Moncao AM, Andersson R et al (2014) Discourse intervention strategies in Alzheimer’s disease: eye-tracking and the effect of visual cues in conversation. Dement Neuropsychol 8:278–284PubMedCentral

44.

Boucart M, Bubbico G, Szaffarczyk S et al (2014) Animal spotting in Alzheimer’s disease: an eye tracking study of object categorization. J Alzheimers Dis 39:181–189

45.

Chau SA, Herrmann N, Eizenman M et al (2015) Exploring visual selective attention towards novel stimuli in Alzheimer’s disease patients. Dement Geriatr Cogn Dis Extra 5:492–502PubMedCentral

46.

Chau SA, Herrmann N, Sherman C et al (2017) Visual selective attention toward novel stimuli predicts cognitive decline in Alzheimer’s disease patients. J Alzheimers Dis 55:1339–1349

47.

de Boer C, van der Steen J, Mattace-Raso F et al (2016) The effect of neurodegeneration on visuomotor behavior in Alzheimer’s disease and Parkinson’s disease. Mot Control 20:1–20

48.

Heuer HW, Mirsky JB, Kong EL et al (2013) Antisaccade task reflects cortical involvement in mild cognitive impairment. Neurology 81:1235–1243PubMedCentral

49.

Chau SA, Chung J, Herrmann N et al (2016) Apathy and attentional biases in Alzheimer’s disease. J Alzheimers Dis 51:837–846

50.

M. Couture, A. Giguere-Rancourt, M. Simard (2018) The impact of cognitive interventions on cognitive symptoms in idiopathic Parkinson’s disease: a systematic review. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; DOI https://doi.org/10.1080/13825585.2018.15134501-22

51.

Kulisevsky J, Pagonabarraga J (2009) Cognitive impairment in Parkinson’s disease: tools for diagnosis and assessment. Mov Disord 24:1103–1110

52.

Daniele A, Lacidogna G (2018) The need for an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson’s disease. Eur J Neurol 25:795–796

53.

Hochstadt J (2009) Set-shifting and the on-line processing of relative clauses in Parkinson’s disease: results from a novel eye-tracking method. Cortex 45:991–1011

54.

Duprez J, Houvenaghel JF, Argaud S et al (2017) Impulsive oculomotor action selection in Parkinson’s disease. Neuropsychologia 95:250–258

55.

Clark US, Neargarder S, Cronin-Golomb A (2010) Visual exploration of emotional facial expressions in Parkinson’s disease. Neuropsychologia 48:1901–1913PubMedCentral

56.

Fielding J, Kilpatrick T, Millist L et al (2009) Antisaccade performance in patients with multiple sclerosis. Cortex 45:900–903

57.

Corfield F, Langdon D (2018) A systematic review and meta-analysis of the brief cognitive assessment for multiple sclerosis (BICAMS). Neurol Ther. https://doi.org/10.1007/s40120-018-0102-3

58.

Pihl-Jensen G, Schmidt MF, Frederiksen JL (2017) Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: a review. Clin Neurophysiol 128:1234–1245

59.

Ashrafi F, Behnam B, Arab Ahmadi M et al (2016) Correlation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test. Med J Islam Repub Iran 30:357PubMedCentral

60.

Niccolai C, Portaccio E, Goretti B et al (2015) A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients. BMC Neurol 15:204PubMedCentral

61.

Messinis L, Kosmidis MH, Lyros E et al (2010) Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Int Rev Psychiatry 22:22–34

62.

Fielding J, Kilpatrick T, Millist L et al (2009) Control of visually guided saccades in multiple sclerosis: disruption to higher-order processes. Neuropsychologia 47:1647–1653

63.

Clough M, Mitchell L, Millist L et al (2015) Ocular motor measures of cognitive dysfunction in multiple sclerosis II: working memory. J Neurol 262:1138–1147

64.

Brau H, Ulrich G, Kriebitzsch R et al (1989) Quantifying functional deficits in patients with multiple sclerosis using a computer-assisted visuomotor tracking procedure. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb 20:84–87

65.

De Santi L, Lanzafame P, Spano B et al (2011) Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study. Neurol Sci 32:67–71

66.

Nygaard GO, de Rodez Benavent SA, Harbo HF et al (2015) Eye and hand motor interactions with the symbol digit modalities test in early multiple sclerosis. Mult Scler Relat Disord 4:585–589

67.

Bostock ECS, Kirkby KC, Garry MI et al (2017) Systematic review of cognitive function in euthymic bipolar disorder and pre-surgical temporal lobe epilepsy. Front Psychiatry 8:133PubMedCentral

68.

Lunn J, Donovan T, Litchfield D et al (2016) Saccadic eye movement abnormalities in children with epilepsy. PLoS One 11:e0160508PubMedCentral

69.

Stafstrom CE (2002) Assessing the behavioral and cognitive effects of seizures on the developing brain. Prog Brain Res 135:377–390

70.

Willment K, Hill M, Baslet G et al (2015) Cognitive impairment and evaluation in psychogenic nonepileptic seizures: an integrated cognitive-emotional approach. Clin EEG Neurosci 46:42–53

71.

Bansal AK, Madhavan R, Agam Y et al (2014) Neural dynamics underlying target detection in the human brain. J Neurosci 34:3042–3055PubMedCentral

72.

Sato W, Kochiyama T, Uono S et al (2016) Rapid gamma oscillations in the inferior occipital gyrus in response to eyes. Sci Rep 6:36321PubMedCentral

73.

Okruszek L, Bala A, Dziekan M et al (2017) Gaze matters! The effect of gaze direction on emotional enhancement of memory for faces in patients with mesial temporal lobe epilepsy. Epilepsy Behav 72:35–38

74.

Nagasawa T, Matsuzaki N, Juhasz C et al (2011) Occipital gamma-oscillations modulated during eye movement tasks: simultaneous eye tracking and electrocorticography recording in epileptic patients. Neuroimage 58:1101–1109PubMedCentral

Titel: Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders
Publikationsdatum: 03.03.2020
Erschienen in: Neurological Sciences / Ausgabe 7/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04310-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders

Abstract

Purpose of review

Findings

Summary

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Purpose of review

Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Altered sensory-motor plasticity in amyotrophic lateral sclerosis and complex regional pain type I syndrome: a shared mechanism?

Scientific publishing in the COVID-19 era: successes and pitfalls

Contrast sensitivity impairment in drug-naïve Parkinson’s disease patients associates with early cognitive decline

The accuracy of aneurysm size in predicting rebleeding after subarachnoid hemorrhage: a meta-analysis

Clinico-diagnostic features of neuralgic amyotrophy in childhood

Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie